Cadila Healthcare Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cadila Healthcare Ltd with three other
companies in this sector in India:
Glenmark Pharmaceuticals Ltd
sales of 91.03 billion Indian Rupees [US$1.26 billion]
of which 100%
Piramal Enterprises Limited
(106.31 billion Indian Rupees [US$1.47 billion]
of which 47%
was Financial Services), and
Dr.Reddy's Laboratories Ltd
(142.03 billion Indian Rupees [US$1.96 billion]
of which 80%
was Global Generics).
Cadila Healthcare Ltd reported sales of 119.05 billion Indian Rupees (US$1.65 billion)
March of 2018.
increase of 26.3%
versus 2017, when the company's sales were 94.30 billion Indian Rupees.